Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Final phase of Estrasorb commercial launch

July 1, 2004

The role of resistin in insulin resistance and obesity

June 30, 2004

Dipeptidyl-peptidase IV inhibitor delays the onset of diabetes in vivo

June 30, 2004

Glumetza NDA accepted for filing

June 30, 2004

New overseas Femprox study

June 30, 2004

New hypoglycemic agents prepared and tested at Servier

June 30, 2004

New alpha-glucosidase inhibitors patented by Indian researchers

June 30, 2004

Oral PTH enters phase I trial under Unigene/GSK collaboration

June 29, 2004

Mechanisms of femoral fracture healing in rats by TP-508

June 28, 2004

R-483 studied in animal models, diabetic patients

June 25, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...